Investing in Healthcare


Experienced healthcare investors Matthew Kamm, Connor Browne, Jeff Jonas, Robert Klaber and Varun Singh describe the unique challenges and opportunities the sector presents, how they're handicapping today's highly uncertain U.S. regulatory environment, and why they see upside in Boston Scientific, Alkermes, Envision Healthcare, Allergan and Cigna.

If you are a subscriber, log in to access the issue and bonus archive: